IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $26,000 | -10.3% | 2,717 | +2.1% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -29.3% | 2,661 | +8.9% | 0.00% | -20.0% |
| Q1 2022 | $41,000 | +13.9% | 2,443 | +29.1% | 0.01% | 0.0% |
| Q4 2021 | $36,000 | -30.8% | 1,893 | -10.9% | 0.01% | -28.6% |
| Q3 2021 | $52,000 | +2.0% | 2,124 | +7.6% | 0.01% | 0.0% |
| Q2 2021 | $51,000 | -19.0% | 1,974 | -1.8% | 0.01% | -22.2% |
| Q1 2021 | $63,000 | -37.6% | 2,010 | -8.6% | 0.01% | -43.8% |
| Q4 2020 | $101,000 | – | 2,198 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |